Invivyd, Inc. (IVVD) stock
IVVDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3048% below fair value
$0.51−0.03 (-4.67%)
Close on Nov 17, 2026Market cap $151.09MP/E –Yield –
Invivyd price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Invivyd's price to sales ratio was 3.0× on Nov 11, 2026, against 10.4× a year earlier. Over the last 2 years it ranged from 2.3× to 53.8×, with a median of 4.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.0× | −7.6 |
| 2025 | Dec 31, 2025 | 10.6× | +6.0 |
| 2024 | Dec 31, 2024 | 4.6× | – |
See a number that looks wrong?